Latest Content

H. Steven Moffic, MD, explores the ongoing challenges for women in the military and society, highlighting the need for recognition of their unique contributions.

A new study reveals the ReCODE program significantly reduces depression in patients with cognitive impairment, enhancing both mood and cognitive health.

Reproductive psychiatrist Sarah Oreck, MD, MS challenges the FDA's claims linking acetaminophen use in pregnancy to autism and ADHD, advocating for informed maternal care.

Explore powerful memoirs that delve into addiction, recovery, and the emotional struggles faced by individuals and families in the journey to healing.

The Ububele Educational and Psychotherapy Trust enhances mental health access in South Africa, focusing on early childhood support and community-based interventions to break cycles of emotional poverty.

Bristol Myers Squibb's BMS-986446 receives FDA Fast Track Designation, aiming to transform early Alzheimer disease treatment by targeting tau pathology.

Socrates’ suicide as an affirmative choice.

Late-life depression poses unique challenges, impacting cognitive function and requiring tailored treatment strategies for older adults.

Explore how lifestyle choices like diet, exercise, and sleep enhance mental health outcomes in psychiatry. Share your insights and experiences today with our October theme!

Lipocine Inc. advances LPCN 1154, an oral treatment for postpartum depression, aiming for rapid relief and improved patient access by 2026.

Explore the dramatic evolution of AI, from early concepts to modern chatbots, and the uncertain future they create for humanity.

What disease states are most prominently featured in recent research? Learn more in this exclusive article.

Exploring the intersection of free speech and psychiatry, this article examines societal risks and the ethical responsibilities of mental health professionals.